Protein identification by accurate mass matrix-assisted laser desorption/ionization imaging of tryptic peptides.

The spatial distribution of proteins in tissue sections can be used to identify potential markers for pathological processes. Tissue sections are often subjected to enzymatic digestion before matrix-assisted laser desorption/ionization (MALDI) imaging. This study is targeted at improving the on-tissue identification of tryptic peptides by accurate mass measurements and complementary off-line liquid chromatography coupled to electrospray ionization tandem mass spectrometry (LC/ESI-MS/MS) analysis. Two adjacent mouse brain sections were analyzed in parallel. The first section was spotted with trypsin and analyzed by MALDI imaging. Direct on-tissue MS/MS experiments of this section resulted in the identification of 14 peptides (originating from 4 proteins). The second tissue section was homogenized, fractionated by ultracentrifugation and digested with trypsin prior to LC/ESI-MS/MS analysis. The number of identified peptides was increased to 153 (corresponding to 106 proteins) by matching imaged mass peaks to peptides which were identified in these LC/ESI-MS/MS experiments. All results (including MALDI imaging data) were based on accurate mass measurements (RMS <2 ppm) and allow a confident identification of tryptic peptides. Measurements based on lower accuracy would have led to ambiguous or misleading results. MS images of identified peptides were generated with a bin width (mass range used for image generation) of Δm/z = 0.01. The application of accurate mass measurements and additional LC/MS measurements increased both the quality and the number of peptide identifications. The advantages of this approach for the analysis of biological tissue sections are demonstrated and discussed in detail. Results indicate that accurate mass measurements are needed for confident identification and specific image generation of tryptic peptides in tissue sections.

[1]  Liam A. McDonnell,et al.  Imaging of peptides in the rat brain using MALDI-FTICR mass spectrometry , 2007, Journal of the American Society for Mass Spectrometry.

[2]  Peter Hoffmann,et al.  Citric acid antigen retrieval (CAAR) for tryptic peptide imaging directly on archived formalin-fixed paraffin-embedded tissue. , 2010, Journal of proteome research.

[3]  I. Fournier,et al.  MALDI imaging of formalin-fixed paraffin-embedded tissues: application to model animals of Parkinson disease for biomarker hunting. , 2008, Journal of proteome research.

[4]  Richard M Caprioli,et al.  Automated acoustic matrix deposition for MALDI sample preparation. , 2006, Analytical chemistry.

[5]  A. Woods,et al.  In situ structural characterization of phosphatidylcholines in brain tissue using MALDI-MS/MS , 2005, Journal of the American Society for Mass Spectrometry.

[6]  B. Spengler,et al.  Identification of leptomeningeal metastasis‐related proteins in cerebrospinal fluid of patients with breast cancer by a combination of MALDI‐TOF, MALDI‐FTICR and nanoLC‐FTICR MS , 2007, Proteomics.

[7]  Ron D. Appel,et al.  ExPASy: the proteomics server for in-depth protein knowledge and analysis , 2003, Nucleic Acids Res..

[8]  B. Spengler,et al.  Matrix vapor deposition/recrystallization and dedicated spray preparation for high-resolution scanning microprobe matrix-assisted laser desorption/ionization imaging mass spectrometry (SMALDI-MS) of tissue and single cells. , 2010, Rapid communications in mass spectrometry : RCM.

[9]  A. Makarov,et al.  Orbitrap Mass Analyzer – Overview and Applications in Proteomics , 2006, Proteomics.

[10]  Alexander Makarov,et al.  Orbitrap Mass Analyzer - Overview and Applications , 2006 .

[11]  Lisa H Cazares,et al.  Imaging Mass Spectrometry of a Specific Fragment of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase Kinase 2 Discriminates Cancer from Uninvolved Prostate Tissue , 2009, Clinical Cancer Research.

[12]  Alexander Makarov,et al.  Dynamic range of mass accuracy in LTQ orbitrap hybrid mass spectrometer , 2006, Journal of the American Society for Mass Spectrometry.

[13]  M. Stoeckli,et al.  Compound and metabolite distribution measured by MALDI mass spectrometric imaging in whole-body tissue sections , 2007 .

[14]  J. Sweedler,et al.  SIMS and MALDI MS imaging of the spinal cord , 2008, Proteomics.

[15]  M. Setou,et al.  Direct MS/MS analysis in mammalian tissue sections using MALDI‐QIT‐TOFMS and chemical inkjet technology , 2006 .

[16]  Loïc Quinton,et al.  MALDI-in source decay applied to mass spectrometry imaging: a new tool for protein identification. , 2010, Analytical chemistry.

[17]  Lingjun Li,et al.  Mass spectral analysis of neuropeptide expression and distribution in the nervous system of the lobster Homarus americanus. , 2010, Journal of proteome research.

[18]  Sander R. Piersma,et al.  High-resolution MALDI imaging mass spectrometry allows localization of peptide distributions at cellular length scales in pituitary tissue sections , 2007 .

[19]  R. Heeren,et al.  Examples of Fourier Transform Ion Cyclotron Resonance Mass Spectrometry Developments: From Ion Physics to Remote Access Biochemical Mass Spectrometry , 2005, European journal of mass spectrometry.

[20]  Richard A Yost,et al.  Imaging of lipids in spinal cord using intermediate pressure matrix-assisted laser desorption-linear ion trap/Orbitrap MS. , 2009, Analytical chemistry.

[21]  M. Clench,et al.  Detergent addition to tryptic digests and ion mobility separation prior to MS/MS improves peptide yield and protein identification for in situ proteomic investigation of frozen and formalin‐fixed paraffin‐embedded adenocarcinoma tissue sections , 2009, Proteomics.

[22]  M. Clench,et al.  Novel molecular tumour classification using MALDI–mass spectrometry imaging of tissue micro-array , 2010, Analytical and bioanalytical chemistry.

[23]  Zoltan Takats,et al.  Histology by mass spectrometry: label-free tissue characterization obtained from high-accuracy bioanalytical imaging. , 2010, Angewandte Chemie.

[24]  Lingjun Li,et al.  In situ tissue analysis of neuropeptides by MALDI FTMS in-cell accumulation. , 2004, Analytical chemistry.

[25]  R. Caprioli,et al.  Identification of proteins directly from tissue: in situ tryptic digestions coupled with imaging mass spectrometry. , 2007, Journal of mass spectrometry : JMS.

[26]  Richard M Caprioli,et al.  Spatial and temporal alterations of phospholipids determined by mass spectrometry during mouse embryo implantation[S] , 2009, Journal of Lipid Research.

[27]  A. Marshall,et al.  Fourier transform ion cyclotron resonance detection: principles and experimental configurations , 2002 .

[28]  Markus Stoeckli,et al.  Molecular imaging of amyloid beta peptides in mouse brain sections using mass spectrometry. , 2002, Analytical biochemistry.

[29]  Michelle L. Reyzer,et al.  MALDI-MS-based imaging of small molecules and proteins in tissues. , 2007, Current Opinion in Chemical Biology.

[30]  Liam A McDonnell,et al.  Imaging mass spectrometry. , 2007, Mass spectrometry reviews.

[31]  B. Spengler,et al.  AP-MALDI imaging of neuropeptides in mouse pituitary gland with 5μm spatial resolution and high mass accuracy , 2011 .

[32]  Zoltan Takats,et al.  Mass spectrometry imaging with high resolution in mass and space (HR2 MSI) for reliable investigation of drug compound distributions on the cellular level , 2011, Analytical and bioanalytical chemistry.

[33]  M. Mann,et al.  On the Proper Use of Mass Accuracy in Proteomics* , 2007, Molecular & Cellular Proteomics.

[34]  L. McDonnell,et al.  Peptide and protein imaging mass spectrometry in cancer research. , 2010, Journal of proteomics.

[35]  Detlev Suckau,et al.  Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry. , 2010, Journal of proteome research.

[36]  I. Fournier,et al.  On-tissue N-terminal peptide derivatizations for enhancing protein identification in MALDI mass spectrometric imaging strategies. , 2009, Analytical chemistry.

[37]  P. Traldi,et al.  MALDI mass spectrometry imaging, from its origins up to today: the state of the art. , 2009, Combinatorial chemistry & high throughput screening.